Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.33K Sell
71
-8
-10% -$923 ﹤0.01% 1664
2026
Q1
$9.58K Hold
79
﹤0.01% 1534
2025
Q4
$11K Hold
79
﹤0.01% 1377
2025
Q3
$11.8K Buy
+79
New +$11K ﹤0.01% 1182

Other funds holding XYL

Salomon & Ludwin's XYL Position: Q2 2026 in Review

Salomon & Ludwin reduced its Xylem (XYL) stake by 10% in Q2 2026, selling an estimated $923 and leaving 71 shares worth $8.33K. The position accounts for ﹤0.01% of the portfolio, ranked #1664.

Salomon & Ludwin first reported a position in XYL in Q3 2025 and has held it in 4 quarters since. The position peaked at $11.8K in Q3 2025. 1,100 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Salomon & Ludwin held 71 shares of Xylem worth $8.33K as of Q2 2026.
  • Salomon & Ludwin sold 8 Xylem shares in Q2 2026, an estimated $923.
  • Xylem made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #1664 holding.
  • Salomon & Ludwin first reported a position in Xylem in Q3 2025 and has held it in 4 quarters since.
  • Salomon & Ludwin's Xylem position peaked at $11.8K in Q3 2025.
  • 1,100 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.